ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Total Facet Arthroplasty System®(TFAS®) Clinical Trial

This study is currently recruiting participants.
Verified by Archus Orthopedics, Inc., July 2008

Sponsored by: Archus Orthopedics, Inc.
Information provided by: Archus Orthopedics, Inc.
ClinicalTrials.gov Identifier: NCT00418197
  Purpose

The Archus Total Facet Arthroplasty System® (TFAS®) is a non-fusion spinal implant indicated for treatment of patients with moderate to severe spinal stenosis. TFAS® replaces the diseased facets following surgical removal. TFAS® offers the surgeon new options for treating spinal stenosis patients, enabling a more comprehensive decompression via complete removal of the facets. TFAS® also offers an alternative to rigid spinal fusion fixation enabling intervertebral motion. The clinical trial is intended to demostrate restoration of stability and sagittal balance to the spine. TFAS® also eliminates the need for painful bone graft harvest from the patient's hip which may be required with fusion procedures.


Condition Intervention Phase
Spinal Stenosis
Low Back Pain
Spondylolisthesis
Lumbar Spinal Stenosis
Leg Pain
Spinal Diseases
Device: Total Facet Arthroplasty System® (TFAS®)
Phase III

MedlinePlus related topics:   Back Pain    Spinal Diseases    Spinal Stenosis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   A Prospective and Randomized Controlled Trial to Evaluate the Safety and Effectiveness of Total Facet Arthroplasty in the Treatment of Degenerative Spinal Stenosis

Further study details as provided by Archus Orthopedics, Inc.:

Primary Outcome Measures:
  • The primary safety and efficacy evaluation endpoints to determine individual patient success are the Zurich Claudication Questionnaire (ZCQ), neurologic status, solid fusion for the control (spinal fusion) group.

Secondary Outcome Measures:
  • Visual Analog Scales (VAS) for Leg and Back pain, SF-36 scores, radiographic measurements.

Estimated Enrollment:   450
Study Start Date:   August 2005

  Eligibility
Ages Eligible for Study:   50 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Degenerative spinal stenosis, central or lateral, at spinal levels L3-L4 or L4-L5
  • Skeletally mature male or female between the ages of 50 and 85 years of age inclusive
  • No greater than Grade I degenerative spondylolisthesis at the index level
  • Persistent leg symptoms,including pain, numbness, burning or tingling for a minimum duration of six months
  • Operative candidates with no more than three levels of degenerative lumbar spinal stenosis requiring decompression
  • Failed to respond to non-operative treatment modalities for a minimum duration of six months

Exclusion Criteria:

  • Male or female less than 50 or greater than 85 years old Grade 2 or higher spondylolisthesis or any retrolisthesis at the index level
  • More than 3 vertebral levels of degenerative spinal stenosis requiring decompression
  • More than 1 vertebral level of degenerative spinal stenosis requiring instrumentation
  • Not available for long term follow-up and interval visits
  • Prior or concurrently planned lumbar fusion or disc replacement at any level of the lumbar spine
  • Two or more previous surgeries to the lumbar spine at the same level to be implanted
  • Is being treated with other devices for the same disorder (e.g. pain control devices)
  • Active systemic infection or infection at the operating site
  • Osteoporosis
  • Known sensitivity to device materials
  • Has an immunosuppressive disorder
  • Has a medical condition that may interfere with clinical evaluations
  • Is obese defined by a patient body mass index greater than 40
  • Has significant scoliosis (Cobb >25°)
  • Is pregnant or planning to become pregnant within the proposed three year investigation
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00418197

Show 22 study locations  Show 22 Study Locations

Sponsors and Collaborators
Archus Orthopedics, Inc.
  More Information


Study ID Numbers:   PR0051
First Received:   January 2, 2007
Last Updated:   July 7, 2008
ClinicalTrials.gov Identifier:   NCT00418197
Health Authority:   United States: Food and Drug Administration

Keywords provided by Archus Orthopedics, Inc.:
spinal stenosis  
low back pain  
spondylolisthesis  
lumbar spinal stenosis
leg pain
spinal diseases

Study placed in the following topic categories:
Pathological Conditions, Anatomical
Spinal Diseases
Signs and Symptoms
Musculoskeletal Diseases
Neurologic Manifestations
Low Back Pain
Constriction, Pathologic
Pain
Spondylolisthesis
Bone Diseases
Back Pain
Spinal Stenosis

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on September 23, 2008




Links to all studies - primarily for crawlers